NIH stops Alzheimer's study involving Celebrex and naproxen (Aleve)

The National Institutes of Health stopped a study testing whether Celebrex or naproxen sold under the brand name Aleve reduced the risk of Alzheimer's when researchers noted an increase in heart attack and strokes among participants. abcnews/AP